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We report a patient with myotonic dystrophy who showed prolonged rocuronium-induced neuromuscular blockade, although
with a fast recovery with sugammadex. During general anesthesia with propofol and remifentanil, the times to spontaneous
recovery of the ﬁrst twitch (T1) of train of four to 10% of control values after an intubating dose of rocuronium 1mg/kg and
an additional dose of 0.2mg/kg were 112min and 62min, respectively. Despite the high sensitivity to rocuronium, sugammadex
2mg/kg administered at a T1 of 10% safely and eﬀectively antagonized rocuronium-induced neuromuscular block in 90s.
1.Introduction
Myotonicdystrophy(MD),anautosomaldominantdisorder,
is the commonest of all myotonic syndromes, with an in-
cidenceofapproximately1in8000.Itischaracterizedbypro-
gressive muscle weakness of the face, neck, pharynx, and
distallimbs,withdiﬃcultyinitiatingmovementsanddelayed
muscle relaxation [1]. Careful anesthetic management is re-
quiredfor MDpatients dueto the likelihood of various coex-
isting disorders, such as cardiac conduction abnormalities,
hypotension, diabetes mellitus, dysphagia, and malignant
hyperthermia [2]. Changes in the sensitivity of these patients
to neuromuscular blocking agents also require special con-
sideration. In particular, the potential requirement of pro-
longed ventilatory support due to hypersensitivity to non-
depolarizing neuromuscular blockade [3, 4], cardiac arrest
provoked by succinylcholine [5], and neostigmine-induced
myotonia [6] should be considered in MD patients. We pres-
ent a patient with MD whose neuromuscular function was
successfully managed with rocuronium and sugammadex
during general anesthesia.
2. Case Presentation
A 37-year-old female patient with MD, weighing 55kg and
154cm tall, was scheduled for open resection of an ovarian
tumor under general anesthesia combined with epidural an-
esthesia. Beside MD, her surgical history included retro-
peritoneal tumor resection under general anesthesia, al-
though details about the surgery and the patient’s perioper-
ativeconditionwerenotknown.Preoperativemanualmuscle
tests revealed mild muscular weakness and myotonia in her
upper limbs. She complained of mild diﬃculty in swallow-
ing, although her respiratory eﬀorts did not seem to be im-
paired. Moderate masseter muscle atrophy led us to predict
diﬃcultywithbagandmaskventilationduringtheinduction
of anesthesia. Routine preoperative blood tests were within
normal ranges with no elevation of creatine kinase levels and
noindicationofliverorrenalinsuﬃciency.Arterialbloodgas
analysis at a FIO2 of 0.21 showed an arterial oxygen tension
of 85mmHg and carbon dioxide tension of 47mmHg.
Premedicationconsistedoforaladministrationof150mg
ranitidine the night before and on the morning of surgery.
On arrival at the operating room, the patient was monitored
with ECG, noninvasive blood pressure, and pulse oximetry.
Epiduralpunctureandcatheterizationwereperformedatthe
Th12-L1 intervertebral space. General anesthesia was in-
d u c e dw i t hf e n t a n y l2µg/kg and a target controlled infusion
of propofol 4µg/mL (Terufusion TCI pump TE-371, Teru-
mo, Tokyo Japan) while the patient received 100% oxygen2 Case Reports in Anesthesiology
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Figure 1: A serial recording of acceleromyography in a patient with myotonic dystrophy. Blue longitudinal bars show T1 height in the train-
of-four responses, and red dots mean the train-of-four ratios. Marked prolongation in durations of rocuronium-induced neuromuscular
block and rapid recovery from neuromuscular block after sugammadex administration are shown.
through an anesthesia facemask. After loss of consciousness,
the left ulnar nerve was stimulated at the wrist with supra-
maximal and square-wave stimuli of 0.2ms duration, which
was delivered in a train-of-four (TOF) mode at 2Hz every
15s. Contraction of the ipsilateral adductor pollicis muscle
was measured using an acceleromyograph (TOF-Watch SX;
Organon, Dublin, Ireland). Immediately after obtaining
baseline levels of TOF responses, the patient received a bolus
of rocuronium 1mg/kg. Complete neuromuscular block was
obtained 75 seconds after rocuronium administration, and
the patient’s trachea was intubated thereafter without any
diﬃculty. Ventilation was controlled with a tidal volume of
500mL and at a rate of 10/min. Anesthesia was maintained
with propofol 2–4µg/mL, remifentanil 0.05–0.3µg/kg/min,
and intermittent epidural injections of 0.375% ropivacaine.
Theﬁrsttwitch(T1)oftrainoffourrecoveredto10%ofcon-
trollevels112minafteradministrationoftheintubatingdose
of rocuronium. At that time, rocuronium 0.2mg/kg was ad-
ministered to obtain complete neuromuscular blockade, as
observed by absent TOF responses. The duration to sponta-
neous recovery to a T1 of 10% of control levels was also pro-
longed to 62min (Figure 1). At the time of uneventful com-
pletion of the surgery, the rocuronium-induced moderate
neuromuscularblockwasstillpresent,andtheobservedTOF
count was only 2. Sugammadex 2mg/kg rapidly antagonized
theneuromuscularblock,suchthattheTOFratioreached0.9
in90s.Severalminutesafterdiscontinuationofpropofoland
remifentanil, the patient could breathe adequately and was
extubated. Oxygen saturation measured by pulse oximetry
remained at 100% while the patient received 100% oxygen
via a facemask. Postanesthetic shivering that could have pre-
cipitated the myotonia was avoided by ensuring adequate
intraoperative warming and temperature maintenance. Ade-
quate postoperative analgesia was provided by continuous
epidural injection of 0.2% ropivacaine without the addition
ofopioids.Thepostoperativecoursewasalsouneventful,and
no respiratory complications were observed.
3. Discussion
Our patient exhibited a higher sensitivity to rocuronium-in-
duced neuromuscular blockade. The time from administra-
tion of rocuronium 1mg/kg until T1 spontaneously reached
1 0 %o ft h ec o n t r o lv a l u ew a sm a r k e d l yl o n g e ri no u rp a -
tient as compared to patients with normal neuromuscular
function (70min [7] ) .T h et i m et a k e nf o rT 1t or e a c h1 0 %i n
our patient (112min) was measured during intravenous
anesthesia using propofol and remifentanil, while the pre-
vious data was observed during anesthesia with sevoﬂurane
[7], which is known to signiﬁcantly prolong the duration of
action of rocuronium to 1.5–2 times [8, 9]. Assuming that
the values observed in the other study were potentiated by
sevoﬂurane, the time from administration of rocuronium
1mg/kg to the recovery of T1 to 10% of the control level
observed in our MD patient seems to have been roughly
doubled.
The response of MD patients to non-depolarizing neu-
romuscular blocking agents is controversial. Increased sen-
sitivity [3, 4], normal response [4] ,a n de v e nr e s i s t a n c e[ 10]
to non-depolarizing neuromuscular block have all been re-
ported. It is likely that the degree of severity of the patho-
logy may determine the sensitivity to neuromuscular block-
ade [11]. To eliminate the risk of prolonged neuro-mus-
cular block and avoid the need for mechanical ventilation
in the post operative period in these patients, avoidan-
ce of the use or reduction in the dose of neuromuscular
blocking agents is recommended [4]. However, vocal cord
injury is a serious concern when tracheal intubation is
performed without neuromuscular blocking agents [12].
In addition, inadvertent patient movement can be trigger-
ed if neuromuscular blockade during surgery is inadequate.Case Reports in Anesthesiology 3
Moreimportantly, our patient had dysphagia associated with
dysfunction of the pharyngeal muscles and the risk of re-
gurgitation of gastric contents [11]. Furthermore, diﬃcu-
lty with bag and mask ventilation during induction of
anesthesia was predicted because of the masseter mus-
cle atrophy. Therefore, rapid sequence intubation using a
high dose of rocuronium was planned to avoid aspira-
tion pneumonia and diﬃcult ventilation, despite the risk
of prolonged neuromuscular blockade. Use of cisatracurium
also seemed like a logical choice because the benzylisoquino-
line compound constantly undergoes pH- and temperature-
dependent Hofmann elimination in plasma and tissues [13].
Although the use of neuromuscular blocking agents without
reversal has been shown to be a signiﬁcant risk factor
for postoperative respiratory complications [14], anticholi-
nesterases should also be avoided in these patients so as
to avoid evoking myotonia, even at the potential cost of resi-
dual neuromuscular blockade postoperatively. These con-
traindications to the use of non-depolarizing muscle re-
laxants and their reversal agents and the availability of sug-
ammadex, which can promptly antagonize rocuronium-in-
duced neuromuscular block even in myasthenic patients
[15], partly contributed to our decision to use high-dose ro-
curonium. In fact, reversibility of rocuronium-induced neu-
romuscular block with sugammadex has been proved to be
adequate even in MD patients with a high sensitivity to ro-
curonium. In such cases, however, the dosing of rocuronium
and sugammadex should be individually optimized by neu-
romuscular monitoring because recurarization may occur
after administration of a lower dose of sugammadex [16].
Acceleromyography was very useful to evaluate the onset
of and recovery from rocuronium-induced neuromuscular
block in our MD patient, although it may underestimate the
degree of neuromuscular block during recovery on the
negative side [11]. It has been reported that T1 is still re-
covering from neuromuscular block even when the TOF
ratioreaches0.9afterreversalwithsugammadex[17].There-
fore, when residual neuromuscular block is suspected by
clinical signs of respiratory insuﬃciency and inadequate
muscular strength, additional doses of sugammadex should
be considered.
It is likely that not only rapid reversal of rocuronium-
induced neuromuscular block with sugammadex but also
short-acting intravenous anesthesia with propofol and remi-
fentanil and postoperative analgesia without opioids all con-
tributed to the rapid recovery of respiratory function seen in
our patient. Given the importance of the marked susceptibil-
ityofMDpatientstoanesthetics,whichmaycauseapneaand
respiratory depression [18], careful titration of propofol and
remifentanil by a target-controlled infusion is thought to be
appropriate when anaesthetizing MD patients.
In conclusion, the combination of rocuronium and sug-
ammadex may allow safe and eﬀective management of neu-
romuscular function during general anesthesia in patients
with MD. Further systematic studies are warranted to verify
the safety and eﬃcacy of perioperative use of rocuronium
and sugammadex in MD patients.
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